Abstract
Purpose : The present research communication describes development of kNN and 3D QSAR models for identification of structural features which are responsible for antimycobacterial activity of Thiazolidinone. Methodology/Approach : In the present work, two predictiveof kNN and 3D QSAR models were developed via utilization of multiple linear regression analysis. MLR analysis was carried out on reported dataset of thiazolidinone as Antimycobacterial. Vlife MDS 4.4 is utilized for development of kNN and 3D QSAR models which were validated via internal test set. Findings : Two different kNN and 3D QSAR models developed for dataset of thiazolidinone molecules as antimycobacterial. The Model A and Model B describes the best selected 3D QSAR model predicting antimycobacterial activity of the thiazolidinone derivatives. 3D QSAR model A is best selected model which indicates steric interaction fields needs to be minimized while electrostatic interaction field needs to be improved for potential increase in antimycobacterial activity. The Model C and D are two selected kNN models for anti-mycobacterial activity of the thiazolidinone derivatives. Model D is better fitted kNN model describing negative contribution of the electrostatic interaction fields and positive contribution of the steric interaction field. Original Value : The review of literature revealed QSAR analysis plays vital role in the development of the novel drug like candidates. Thiazolidinone derivatives were reported for their antimycobacterial potential but their quantitative measures were not reported. These facts prompted us to for development of QSAR models which will be utilized for development of potent and selective antimycobacterial agents. Conclusion : The study revealed that 3DQSAR model A and kNN model D better describes the antimycobacterial potential of the thiazolidinone derivatives. Substitution of the smaller groups on the aromatic ring bearing thiazolidinone nucleus will increase the antimycobacterial potential of the thiazolidinone derivatives.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have